DrugDashboards

Doxazosin mesylate

doxazosin mesylate · DOXAZOSIN MESYLATE 1 mg/1 · Tablet · Oral · Mylan Pharmaceuticals Inc.

NDC 59762-1388-07 · 100 TABLET in 1 BOTTLE · NDA AUTHORIZED GENERIC · View full market →

The short version

12 companies supply this market — deep enough that no single failure threatens the supply. The price has held steady around $0.0772 per unit over the past year. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Pharmacies pay (NADAC)$0.0772per EAinvoice-surveyed acquisition cost · Aug 19, 2026
  • Part D plans paid (avg)$0.2035per dosage unitgross, before rebates — matched by drug name · 2024
  • Federal ceiling (Big4)$0.3132per unitMylan Pharmaceuticals, Inc. · Jan 1, 2026405% of what pharmacies pay — higher than 90% of drugs with this benchmark
  • Medicaid generic ceiling (FUL)$0.0772per TABweighted avg manufacturer price $0.0316 · Aug 1, 2026100% of what pharmacies pay — higher than 10% of drugs with this benchmark

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$0.05$0.1Jul 2025Sep 2026$0.0772
14 price points · per EA · dashed = manufacturer avg (WAMP)Source: CMS NADAC

Estimated fill cost

#30 count
$2.32
#90 count
$6.95

Estimates: latest NADAC unit price × quantity. Pharmacy acquisition cost only — excludes dispensing fees, markup, and insurance terms.

Supply fragility

0● Low risk

Nothing here is signaling trouble: several manufacturers, no current shortage, no recent serious recalls, stable pricing. In drug supply, boring is the good outcome.

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for doxazosin mesylate (oral solid) in the next 90 days

sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Regulatory

Application
NDA019668
TE code
AB
Approval date
Nov 2, 1990
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of doxazosin mesylate (Tablet)

LabelerStrengthFirst seenLast seen
Aphena Pharma Solutions - Tennessee, LLCDOXAZOSIN MESYLATE 4 mg/1Jul 15, 2026Sep 3, 2026
A-S Medication SolutionsDOXAZOSIN MESYLATE 2 mg/1Jul 15, 2026Sep 2, 2026
A-S Medication SolutionsDOXAZOSIN MESYLATE 8 mg/1Jul 15, 2026Sep 2, 2026
Aphena Pharma Solutions - Tennessee, LLCDOXAZOSIN MESYLATE 2 mg/1Jul 15, 2026Sep 2, 2026
Aurobindo Pharma LimitedDOXAZOSIN MESYLATE 1 mg/1Jul 15, 2026Sep 2, 2026
Aurobindo Pharma LimitedDOXAZOSIN MESYLATE 2 mg/1Jul 15, 2026Sep 2, 2026
Aurobindo Pharma LimitedDOXAZOSIN MESYLATE 4 mg/1Jul 15, 2026Sep 2, 2026
Aurobindo Pharma LimitedDOXAZOSIN MESYLATE 8 mg/1Jul 15, 2026Sep 2, 2026
Bryant Ranch PrepackDOXAZOSIN MESYLATE 1 mg/1Jul 15, 2026Sep 2, 2026
Bryant Ranch PrepackDOXAZOSIN MESYLATE 2 mg/1Jul 15, 2026Sep 2, 2026
Chartwell RX, LLCDOXAZOSIN MESYLATE 8 mg/1Jul 15, 2026Sep 2, 2026
Chartwell RX, LLCDOXAZOSIN MESYLATE 1 mg/1Jul 15, 2026Sep 2, 2026
Chartwell RX, LLCDOXAZOSIN MESYLATE 2 mg/1Jul 15, 2026Sep 2, 2026
Chartwell RX, LLCDOXAZOSIN MESYLATE 4 mg/1Jul 15, 2026Sep 2, 2026
Mylan Pharmaceuticals Inc.DOXAZOSIN MESYLATE 4 mg/1Jul 15, 2026Sep 2, 2026
Mylan Pharmaceuticals Inc.DOXAZOSIN MESYLATE 8 mg/1Aug 5, 2026Sep 2, 2026
Mylan Pharmaceuticals Inc.DOXAZOSIN MESYLATE 1 mg/1Jul 15, 2026Sep 2, 2026
Northwind Health Company, LLCDOXAZOSIN MESYLATE 4 mg/1Jul 15, 2026Sep 2, 2026
Pfizer Manufacturing Deutschland GmbHDOXAZOSIN MESYLATE 1 mg/1Jul 15, 2026Sep 2, 2026
Pfizer Manufacturing Deutschland GmbHDOXAZOSIN MESYLATE 2 mg/1Jul 15, 2026Sep 2, 2026
Pfizer Manufacturing Deutschland GmbHDOXAZOSIN MESYLATE 4 mg/1Jul 15, 2026Sep 2, 2026
Pfizer Manufacturing Deutschland GmbHDOXAZOSIN MESYLATE 8 mg/1Jul 15, 2026Sep 2, 2026
Teva Pharmaceuticals USA, Inc.DOXAZOSIN MESYLATE 1 mg/1Jul 15, 2026Sep 2, 2026
Teva Pharmaceuticals USA, Inc.DOXAZOSIN MESYLATE 8 mg/1Jul 15, 2026Sep 2, 2026
Teva Pharmaceuticals USA, Inc.DOXAZOSIN MESYLATE 2 mg/1Jul 15, 2026Sep 2, 2026
Teva Pharmaceuticals USA, Inc.DOXAZOSIN MESYLATE 4 mg/1Jul 15, 2026Sep 2, 2026
Unichem Laboratories Limited, IndiaDOXAZOSIN MESYLATE 2 mg/1Jul 15, 2026Sep 2, 2026
Unichem Pharmaceuticals (USA), Inc.DOXAZOSIN MESYLATE 8 mg/1Jul 15, 2026Sep 2, 2026
Unichem Pharmaceuticals (USA), Inc.DOXAZOSIN MESYLATE 2 mg/1Jul 15, 2026Sep 2, 2026
Unichem Pharmaceuticals (USA), Inc.DOXAZOSIN MESYLATE 1 mg/1Jul 15, 2026Sep 2, 2026
Unichem Pharmaceuticals (USA), Inc.DOXAZOSIN MESYLATE 4 mg/1Jul 15, 2026Sep 2, 2026
Upsher-Smith laboratories, LLCDOXAZOSIN MESYLATE 8 mg/1Jul 15, 2026Sep 2, 2026
Upsher-Smith laboratories, LLCDOXAZOSIN MESYLATE 4 mg/1Jul 15, 2026Sep 2, 2026
Upsher-Smith laboratories, LLCDOXAZOSIN MESYLATE 1 mg/1Jul 15, 2026Sep 2, 2026
Upsher-Smith laboratories, LLCDOXAZOSIN MESYLATE 2 mg/1Jul 15, 2026Sep 2, 2026
Bryant Ranch PrepackDOXAZOSIN MESYLATE 4 mg/1Jul 15, 2026Aug 31, 2026
A-S Medication SolutionsDOXAZOSIN MESYLATE 4 mg/1Jul 15, 2026Aug 29, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Doxazosin mesylate — NDC 59762-1388-07," retrieved September 3, 2026, https://drugdashboards.com/drug/59762138807.

Free to cite with attribution — see how the data is put together.